Americans are adjusting to life in the “new normal” with more than half (56%) saying COVID-19 is…
Author: admin
18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Michel Vounatsos,…
Forian Inc. Announces $12 Million Private Placement of Common Stock
Forian Inc. (Nasdaq:FORA), a provider of software and technology-enabled services for the healthcare and cannabis industries, announced…
Global Healthcare Mobility Solutions Market Forecast 2021-2027 – Opportunities Served by COVID-19 Pandemic & Mobile Clinics
The “Healthcare Mobility Solutions Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Products and…
Tampa General Hospital is One of the Only Hospitals in Florida to Perform On-Site COVID-19 Variant Sequencing Testing
Tampa General Hospital’s Esoteric Research Lab, in collaboration with USF Health Morsani College of Medicine, is…
New Miami-based initiative AccurePCI to catalyze personalized medicine innovation in Miami-Dade
AccurePCI, a project partnership of Miami foundation Global CoCreation Lab and Silicon Valley-based Cipherome announced today, will address…
Pulmatrix to Regain Full Rights to PUR1800 and Narrow Spectrum Kinase Inhibitor Portfolio
Pulmatrix, Inc. (NASDAQ: PULM), is re-issuing this press release solely to correct inadvertent typographical errors under the…
Discovery Behavioral Health Opens New Center in Beavercreek, OR for Adolescent Mental Health Services
Discovery Behavioral Health, Inc., an expanding network of evidence-based mental health, substance use and eating disorder…
Ascentage Pharma Releases Preclinical Data of Its Core Drug Candidates at AACR Annual Meeting 2021
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers,…
Economists predict vaccine delays could cost up to $1.4 billion, after Morrison government ditches targets
Prime Minister Scott Morrison has announced the government has no plans to set new targets for…